Multidrug resistance protein 1 protects the oropharyngeal mucosal layer and the testicular tubules against drug-induced damage

J Wijnholds, GL Scheffer, M van der Valk… - The Journal of …, 1998 - rupress.org
J Wijnholds, GL Scheffer, M van der Valk, P van der Valk, JH Beijnen, RJ Scheper, P Borst
The Journal of experimental medicine, 1998rupress.org
The multidrug resistance protein 1 (MRP1) gene encodes a transporter protein that helps to
protect cells against xenobiotics. Elevated levels of MRP1 in tumor cells can result in active
extrusion of a wide range of (anticancer) drugs with different cellular targets, a phenomenon
called multidrug resistance (MDR). To explore the protective function of the mouse mrp1
protein during drug treatment, we investigated the toxicity caused by the anticancer drug
etoposide-phosphate (ETOPOPHOS) in mice lacking the mrp1 gene (mrp1−/− mice). We …
The multidrug resistance protein 1 (MRP1) gene encodes a transporter protein that helps to protect cells against xenobiotics. Elevated levels of MRP1 in tumor cells can result in active extrusion of a wide range of (anticancer) drugs with different cellular targets, a phenomenon called multidrug resistance (MDR). To explore the protective function of the mouse mrp1 protein during drug treatment, we investigated the toxicity caused by the anticancer drug etoposide-phosphate (ETOPOPHOS) in mice lacking the mrp1 gene (mrp1−/− mice). We show here that the lack of mrp1 protein results in increased etoposide-induced damage to the mucosa of the oropharyngeal cavity and to the seminiferous tubules of the testis. The high concentrations of mrp1 that we find in the basal layers of the oropharyngeal mucosa and in the basal membrane of the Sertoli cells in the testis apparently protect wild-type mice against this tissue damage. We also find drug-induced polyuria in mrp1−/− mice, which correlates with the presence of mrp1 protein in the urinary collecting tubules, the major site of kidney water reabsorption. Our results indicate that specific inhibitors of MRP1 used to reverse MDR, in combination with carcinostatic drugs transported by MRP1, might lead to drug-induced mucositis, (temporary) infertility, and diabetes insipidus.
rupress.org